• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟代脱氧葡萄糖正电子发射断层扫描(FDG PET)作为缺血性心肌病患者心脏再同步化治疗反应的预测指标

FDG PET as a predictor of response to resynchronisation therapy in patients with ischaemic cardiomyopathy.

作者信息

van Campen C M C, Visser Frans C, van der Weerdt Arno P, Knaapen Paul, Comans Emile F I, Lammertsma Adriaan A, de Cock Carel C, Visser Cees A

机构信息

Department of Cardiology, VU University Medical Centre, Amsterdam, The Netherlands.

出版信息

Eur J Nucl Med Mol Imaging. 2007 Mar;34(3):309-15. doi: 10.1007/s00259-006-0235-y. Epub 2006 Sep 26.

DOI:10.1007/s00259-006-0235-y
PMID:17021810
Abstract

PURPOSE

Although resynchronisation therapy (CRT) is a promising addition to heart failure therapy, a substantial number of patients do not respond to CRT. As FDG PET has routinely been used for prediction of improvement after revascularisation in ischaemic cardiomyopathy, it was hypothesised that there is also a relationship between the extent of viable tissue and improvement as a result of CRT.

METHODS

Thirty-nine patients with ischaemic cardiomyopathy (ejection fraction 27 +/- 9%) and a wide QRS complex underwent temporary pacing to determine the optimal pacing combination, i.e. that with the highest increase in cardiac index (CI) compared with baseline (measured by Doppler echocardiography). All patients also underwent FDG PET imaging. In 19 patients, CI measurements were repeated 10-12 weeks after permanent biventricular pacemaker implantation.

RESULTS

Echocardiography (13-segment model) showed a mean of 9.8 +/- 1.6 dyssynergic segments, with preserved FDG uptake in 4.1 +/- 2.4 segments. CI improvement at the optimal pacing site was 20 +/- 9%. There was a linear relationship between the extent of viable tissue and CI improvement during pacing (p < 0.001). Using a cut-off value of more than three viable segments (ROC analysis), FDG PET had a sensitivity of 72% and a specificity of 71% for detection of the presence of haemodynamic improvement (i.e. a CI improvement >15%). The relation between CI improvement and viable tissue was similar at follow-up.

CONCLUSION

A correlation was found between the extent of viable tissue and the haemodynamic response to CRT in patients with ischaemic cardiomyopathy, suggesting that FDG PET imaging may be useful to discriminate between responders and non-responders to CRT.

摘要

目的

尽管心脏再同步治疗(CRT)是心力衰竭治疗中一项很有前景的补充治疗方法,但仍有相当数量的患者对CRT无反应。由于氟代脱氧葡萄糖正电子发射断层扫描(FDG PET)已常规用于预测缺血性心肌病血管重建术后的改善情况,因此推测存活心肌组织范围与CRT导致的改善之间也存在关联。

方法

39例缺血性心肌病患者(射血分数27±9%)且QRS波增宽,接受临时起搏以确定最佳起搏组合,即与基线相比心脏指数(CI)增加幅度最大的组合(通过多普勒超声心动图测量)。所有患者均接受FDG PET成像。19例患者在植入永久性双心室起搏器10 - 12周后重复测量CI。

结果

超声心动图(13节段模型)显示平均有9.8±1.6个节段运动不同步,4.1±2.4个节段FDG摄取保留。最佳起搏部位的CI改善为20±9%。起搏期间存活心肌组织范围与CI改善之间存在线性关系(p<0.001)。使用三个以上存活节段的截断值(ROC分析),FDG PET检测血流动力学改善(即CI改善>15%)的敏感性为72%,特异性为71%。随访时CI改善与存活组织之间的关系相似。

结论

在缺血性心肌病患者中,发现存活心肌组织范围与CRT的血流动力学反应之间存在相关性,这表明FDG PET成像可能有助于鉴别CRT的反应者和无反应者。

相似文献

1
FDG PET as a predictor of response to resynchronisation therapy in patients with ischaemic cardiomyopathy.氟代脱氧葡萄糖正电子发射断层扫描(FDG PET)作为缺血性心肌病患者心脏再同步化治疗反应的预测指标
Eur J Nucl Med Mol Imaging. 2007 Mar;34(3):309-15. doi: 10.1007/s00259-006-0235-y. Epub 2006 Sep 26.
2
Selection of heart failure patients for cardiac resynchronisation therapy: a role for PET?
Eur J Nucl Med Mol Imaging. 2007 Mar;34(3):307-8. doi: 10.1007/s00259-006-0286-0.
3
The impact of myocardial viability on the clinical outcome of cardiac resynchronization therapy.心肌存活能力对心脏再同步治疗临床结局的影响。
J Cardiovasc Electrophysiol. 2009 Jan;20(1):50-7. doi: 10.1111/j.1540-8167.2008.01294.x. Epub 2008 Sep 17.
4
Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.序贯氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)能够可靠地预测局部晚期直肠癌对新辅助放化疗的反应。
Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1583-93. doi: 10.1007/s00259-007-0426-1. Epub 2007 May 15.
5
Extent of viability to predict response to cardiac resynchronization therapy in ischemic heart failure patients.预测缺血性心力衰竭患者心脏再同步治疗反应的存活范围
J Nucl Med. 2006 Oct;47(10):1565-70.
6
Volume overload modulates effects of cardiac resynchronization therapy independently of myocardial reperfusion: results of the RESYNC study.
J Cardiovasc Med (Hagerstown). 2007 Aug;8(8):575-81. doi: 10.2459/01.JCM.0000281700.38736.85.
7
Echocardiography-based qualification and response assessment to cardiac resynchronisation therapy in patients with chronic heart failure. The matrix metalloproteinase-9 substudy.基于超声心动图的慢性心力衰竭患者心脏再同步治疗的适应证和疗效评估。基质金属蛋白酶-9 亚组研究。
Kardiol Pol. 2011;69(10):1043-51.
8
Prognostic performance of quantitative PET tools for stratification of patients with ischemic cardiomyopathy undergoing myocardial viability assessment.用于对接受心肌存活评估的缺血性心肌病患者进行分层的定量PET工具的预后性能。
Nucl Med Commun. 2008 Nov;29(11):970-81. doi: 10.1097/MNM.0b013e3283073b60.
9
Assessment of intraventricular mechanical dyssynchrony and prediction of response to cardiac resynchronization therapy: comparison between tissue Doppler imaging and real-time three-dimensional echocardiography.评估心室内机械不同步及预测心脏再同步治疗反应:组织多普勒成像与实时三维超声心动图的比较
J Am Soc Echocardiogr. 2009 Sep;22(9):1047-54. doi: 10.1016/j.echo.2009.06.012. Epub 2009 Jul 31.
10
Comparison of the prognostic value of SPECT after nitrate administration and metabolic imaging by PET in patients with ischaemic left ventricular dysfunction.
Eur J Nucl Med Mol Imaging. 2007 Apr;34(4):558-62. doi: 10.1007/s00259-006-0304-2. Epub 2006 Dec 20.

引用本文的文献

1
Phase analysis of gated PET in the evaluation of mechanical ventricular synchrony: A narrative overview.门控 PET 相位分析评价机械心室同步性:叙述性综述。
J Nucl Cardiol. 2019 Dec;26(6):1904-1913. doi: 10.1007/s12350-019-01670-7. Epub 2019 Mar 4.
2
Influence of SPECT attenuation correction on the quantification of hibernating myocardium as derived from combined myocardial perfusion SPECT and ¹⁸F-FDG PET.单光子发射计算机断层扫描(SPECT)衰减校正对联合心肌灌注SPECT与¹⁸F-氟代脱氧葡萄糖(¹⁸F-FDG)正电子发射断层扫描(PET)所得冬眠心肌定量分析的影响
J Nucl Cardiol. 2014 Jun;21(3):578-87. doi: 10.1007/s12350-014-9882-8. Epub 2014 Mar 15.
3

本文引用的文献

1
Prediction of functional recovery after revascularization in patients with coronary artery disease and left ventricular dysfunction by gated FDG-PET.门控FDG-PET对冠心病合并左心室功能不全患者血运重建后功能恢复的预测
J Nucl Cardiol. 2006 Mar-Apr;13(2):210-9. doi: 10.1007/BF02971245.
2
Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy.后外侧瘢痕组织对心脏再同步治疗后临床及超声心动图改善情况的影响。
Circulation. 2006 Feb 21;113(7):969-76. doi: 10.1161/CIRCULATIONAHA.105.543678. Epub 2006 Feb 13.
3
Echocardiographic parameters of ventricular dyssynchrony validation in patients with heart failure using sequential biventricular pacing.
Pulmonary 2-deoxy-2-[(18)F]-fluoro-d-glucose uptake is low in treated patients with idiopathic pulmonary arterial hypertension.
特发性肺动脉高压治疗患者的肺部 2-脱氧-2-[(18)F]-氟代-d-葡萄糖摄取较低。
Pulm Circ. 2013 Sep;3(3):647-53. doi: 10.1086/674335. Epub 2013 Nov 18.
4
The amount of viable and dyssynchronous myocardium is associated with response to cardiac resynchronization therapy: initial clinical results using multiparametric ECG-gated [18F]FDG PET.存活且失同步的心肌量与心脏再同步治疗反应相关:应用多参数心电图门控 [18F]FDG PET 的初步临床结果。
Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1876-83. doi: 10.1007/s00259-013-2516-6. Epub 2013 Aug 1.
5
Radionuclide imaging of myocardial metabolism.心肌代谢的放射性核素成像。
Circ Cardiovasc Imaging. 2010 Mar;3(2):211-22. doi: 10.1161/CIRCIMAGING.109.860593.
6
Role of cardiac MRI and nuclear imaging in cardiac resynchronization therapy.心脏磁共振成像和核医学成像在心脏再同步治疗中的作用。
Nat Rev Cardiol. 2009 Dec;6(12):759-70. doi: 10.1038/nrcardio.2009.189. Epub 2009 Nov 3.
7
Translation of myocardial metabolic imaging concepts into the clinics.心肌代谢成像概念向临床的转化。
Cardiol Clin. 2009 May;27(2):291-310, Table of Contents. doi: 10.1016/j.ccl.2008.12.004.
8
The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial.在CARE-HF试验中,病因对接受心脏再同步治疗患者预后的影响。
Eur Heart J. 2009 Apr;30(7):782-8. doi: 10.1093/eurheartj/ehn577. Epub 2009 Jan 24.
9
Integrated PET/CT in the assessment of etiology and viability in ischemic heart failure.PET/CT一体化成像在评估缺血性心力衰竭的病因及存活心肌方面的应用
Curr Heart Fail Rep. 2008 Sep;5(3):136-42. doi: 10.1007/s11897-008-0022-0.
10
Left ventricular function and visual phase analysis with equilibrium radionuclide angiography in patients with biventricular device.双心室装置患者的左心室功能及平衡放射性核素血管造影的视觉相位分析
Eur J Nucl Med Mol Imaging. 2008 May;35(5):912-21. doi: 10.1007/s00259-008-0714-4. Epub 2008 Jan 29.
使用序贯双心室起搏对心力衰竭患者心室不同步进行超声心动图参数验证
J Am Coll Cardiol. 2004 Dec 7;44(11):2157-65. doi: 10.1016/j.jacc.2004.08.065.
4
Effects of cardiac resynchronization therapy on myocardial perfusion reserve.
Circulation. 2004 Aug 10;110(6):646-51. doi: 10.1161/01.cir.0000138108.68719.c1.
5
Improvement of left ventricular wall synchronization with multisite ventricular pacing in heart failure: a prospective study using Doppler tissue imaging.多部位心室起搏改善心力衰竭患者左心室壁同步性:一项使用多普勒组织成像的前瞻性研究
Eur J Heart Fail. 2004 Mar 1;6(2):203-12. doi: 10.1016/j.ejheart.2003.10.008.
6
Cardiac resynchronisation may reduce all-cause mortality: meta-analysis of preliminary COMPANION data with CONTAK-CD, InSync ICD, MIRACLE and MUSTIC.
Int J Cardiol. 2004 Feb;93(2-3):101-3. doi: 10.1016/j.ijcard.2003.10.002.
7
Postinjection transmission scanning in myocardial 18F-FDG PET studies using both filtered backprojection and iterative reconstruction.在心肌18F-FDG PET研究中,使用滤波反投影和迭代重建进行注射后发射扫描。
J Nucl Med. 2004 Feb;45(2):169-75.
8
Myocardial perfusion imaging using gated SPECT in heart failure patients undergoing cardiac resynchronization therapy.在接受心脏再同步治疗的心力衰竭患者中使用门控单光子发射计算机断层扫描进行心肌灌注成像。
J Nucl Med. 2004 Feb;45(2):164-8.
9
Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography.心脏再同步治疗后左心室功能的改善可通过组织多普勒成像超声心动图预测。
Circulation. 2004 Mar 2;109(8):978-83. doi: 10.1161/01.CIR.0000116765.43251.D7. Epub 2004 Feb 9.
10
Cardiac resynchronization therapy homogenizes myocardial glucose metabolism and perfusion in dilated cardiomyopathy and left bundle branch block.心脏再同步治疗可使扩张型心肌病合并左束支传导阻滞患者的心肌葡萄糖代谢和灌注均匀化。
J Am Coll Cardiol. 2003 May 7;41(9):1523-8. doi: 10.1016/s0735-1097(03)00257-2.